Theralizumab Biosimilar - Research Grade,ichor.bio,ICH5023
Detects human CD28. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Theralizumab.
Host
CHO cells
Reactivity
Human
Platform ID
BAB077205895
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameTheralizumab Biosimilar - Research Grade
Cat. No.ICH5023
Accession NumberP10747
HostCHO cells
IsotypeHuman IgG4
ReactivityHuman
Concentration5mg/ml
TargetCD28
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only
Scientific Background
Theralizumab GN1412 is a humanised monoclonal antibody that not only binds to, but is a strong agonist for, the CD28 receptor of the immune systemï؟½s T cells. CD28 is the co-receptor for the T cell receptor; It binds to receptors on the interacting partn
Synonyms
TGN1412, CD28-SuperMAB, TAB08
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.